Trials that use: Covariate adjustment
5,848 results
- Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.: Complete Statistical AnalysisIndependent statistical analysis of Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged…
- Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02796300).
- Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint…
- Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers: primary endpoint results, effect estimate with confidence interval,…
- Study to Demonstrate Cognitive Enhancing Effects of BF2.649: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate Cognitive Enhancing Effects of BF2.649: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00690274).
- Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United States (US)-Lantus®, and European Union (EU)-Lantus®: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United States (US)-Lantus®, and European Union (EU)-Lantus®: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA: primary endpoint results, effect estimate with…
- Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information: Complete Statistical AnalysisIndependent statistical analysis of Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332: Complete Statistical AnalysisIndependent statistical analysis of Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain: Complete Statistical AnalysisIndependent statistical analysis of Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals’ Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older: primary endpoint results, effect estimate with…
- Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals’ Herpes Zoster Vaccine GSK1437173A: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Evaluate Immunogenicity and Safety of GSK Biologicals’ Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2…
- Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants: primary endpoint results, effect estimate with confidence interval,…
- Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to
- Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I: primary endpoint results,…
- Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects…
- Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity: primary endpoint results,…
- Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Evaluate the Effectiveness of Test Dentifrice in the Relief of Dentinal Hypersensitivity: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Effectiveness of Test Dentifrice in the Relief of Dentinal Hypersensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1): primary endpoint…
- Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants: primary endpoint results, effect…
- Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin’s Lymphoma (NHL): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL): primary endpoint results,…
- Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome: primary endpoint results, effect estimate with confidence interval,…
- Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary…
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence…
- Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder: primary endpoint results, effect estimate…
- Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH): primary endpoint results,…
- Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals’ Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals’ Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50…
- Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients: Complete Statistical AnalysisIndependent statistical analysis of Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients: primary endpoint results, effect estimate with confidence…
- Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…